The Glycemic Indices of Five Common Varieties of Dates in the Tested Among Healthy and Diabetic Subjects

NCT01307904 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2011-03-03

No results posted yet for this study

Summary

The main objectives of this study is to measure the composition of five common types of dates (Fara'd, Lulu, Abu ouma'n, Dabbas and Khalas) and to calculate their Glycemic Indices (GI) of these dates tested in healthy and diabetic subjects. Thirteen healthy volunteers and ten subjects with type 2 diabetes mellitus were enrolled in the study.

The dates' flesh composition analysis showed that the dates contain a high percentage of carbohydrate (total sugars, 65-68%).

The measured mean glycemic indices of the dates among healthy individuals were 54.0, 53.5, 46.3, 49.1 and 55.1 for Fara'd, Lulu, Abu Ouma'n, Dabbas and Khalas, respectively. Corresponding mean glycemic indices among individuals with type 2 diabetes were very similar 46.1, 43.8, 51.8, 50.2, and 53.0. Thus the tested five varieties of the dates are classified as low glycemic index food items.

Conditions

Interventions

OTHER

Glucose

Each healthy and Diabetic volunteers received 50 grams of glucose

OTHER

Dates

Each healthy and diabetic volunteers received 50 grams equivalent of carbohydrates of each of the five selected dates, on five separate days.

Sponsors & Collaborators

  • Abu Dhabi Food Control Authority

    collaborator OTHER_GOV
  • United Arab Emirates University

    lead OTHER

Principal Investigators

  • Juma M Alkaabi, MD · Faculty of Medicine and Health Sciences, UAE University

  • Bayan Al-Dabbagh, PhD · Faculty of Medicine and Health Sciences, UAE University

  • Professor Hussein saadi, MD · Faculty of Medicine and Health Sciences, UAE University

  • Professor Salah Gariballa, FRCP · Faculty of Medicine and Health Sciences, UAE University

  • Ahmed Shakeel, PhD · Abu Dhabi Food Control Authority

  • Mustafa Al Gazali, PhD · Abu Dhabi Food Control Authority

Study Design

Allocation
NON_RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-03-31
Completion
2010-07-31

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01307904 on ClinicalTrials.gov